Notes Payable - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 3 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 22, 2023 |
Jun. 04, 2021 |
Jun. 30, 2023 |
Mar. 31, 2024 |
Sep. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2022 |
|
Line of Credit Facility [Line Items] | |||||||
Accretion of debt discount | $ 0 | $ 350 | |||||
Horizon & Powerscourt Notes | Notes Payable | |||||||
Line of Credit Facility [Line Items] | |||||||
Principal amount | $ 35,000 | ||||||
Principal payments on Notes | $ 14,300 | $ 6,000 | $ 15,000 | ||||
Horizon & Powerscourt Notes | Notes Payable | Warrant liability | |||||||
Line of Credit Facility [Line Items] | |||||||
Sale of stock (in shares) | 148 | ||||||
Exercise price per share (in dollars per share) | $ 7,488 | ||||||
Warrants or rights exercisable term | 10 years | ||||||
Accretion of debt discount | $ 900 |
X | ||||||||||
- Definition Class of Warrant or Right, Warrants or Rights Exercisable, Term No definition available.
|
X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|